Pergolizzi Joseph V, Zampogna Gianpietro, Taylor Robert, Gonima Edmundo, Posada Jose, Raffa Robert B
Department of Medicine, Johns Hopkins University School of MedicineBaltimore, MD, USA; Department of Anesthesiology, Georgetown University School of MedicineWashington, DC, USA; Department of Pharmacology, Temple University School of MedicinePhiladelphia, PA, USA.
NEMA Research Naples, FL, USA.
Front Pharmacol. 2016 Mar 1;7:42. doi: 10.3389/fphar.2016.00042. eCollection 2016.
Most patients who present with cancer have advanced disease and often suffer moderate to severe pain. Opioid therapy can be safe and effective for use in cancer patients with pain, but there are rightful concerns about inappropriate opioid use even in the cancer population. Since cancer patients live longer than ever before in history (and survivors may have long exposure times to opioid therapy), opioid misuse among cancer patients is an important topic worthy of deeper investigation. Cancer patients with pain must be evaluated for risk factors for potential opioid misuse and aberrant drug-taking behaviors assessed. A variety of validated screening tools should be used. Of particular importance is the fact that pain in cancer patients changes frequently, whether it is related to their underlying disease (progression or remission), pain related to treatment (such as painful chemotherapy-induced peripheral neuropathy), and concomitant pain unrelated to cancer (such as osteoarthritis, headache, or back pain). Fortunately, clinicians can use universal precautions to help reduce the risk of opioid misuse while still assuring that cancer patients get the pain therapy they need. Another important new "tool" in this regard is the emergence of abuse-deterrent opioid formulations.
大多数罹患癌症的患者病情已发展至晚期,常常承受着中度到重度的疼痛。阿片类药物疗法对于患有疼痛的癌症患者而言可以是安全有效的,但是即便在癌症患者群体中,对于阿片类药物的不当使用也存在合理的担忧。由于癌症患者比历史上任何时期的生存期都更长(且幸存者可能长期接受阿片类药物治疗),癌症患者中的阿片类药物滥用是一个值得深入研究的重要课题。必须评估患有疼痛的癌症患者潜在阿片类药物滥用的风险因素,并对异常用药行为进行评估。应使用各种经过验证的筛查工具。特别重要的是,癌症患者的疼痛经常发生变化,这与他们的基础疾病(进展或缓解)、与治疗相关的疼痛(如化疗引起的疼痛性周围神经病变)以及与癌症无关的伴随疼痛(如骨关节炎、头痛或背痛)有关。幸运的是,临床医生可以采用通用预防措施来帮助降低阿片类药物滥用的风险,同时仍确保癌症患者获得所需的疼痛治疗。在这方面,另一个重要的新“工具”是抗滥用阿片类药物制剂的出现。